Pharmaceuticals · Sales VP · After Networking
Thank You for Pharmaceuticals Sales VP: After Networking
The query is practical: what should a thank-you email to a Pharmaceuticals Sales VP say for after networking? Start with a direct answer, add one proof point about follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, and close with share the resource you promised, or ask if they'd like a short continuation.
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Why does this thank you work for a Pharmaceuticals Sales VP?
- Reflect back one insight they shared.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
- Remind them of the exact topic you both lingered on.
- Send it while the moment is still in their memory.
When should I send this to a Pharmaceuticals Sales VP?
Send it the same day. Thanks that arrive a week later feel like a task. Within 24 to 48 hours while they still remember your face or handle. For this combo, treat "1-2 days" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome. Tuesday through Thursday mid-morning local time is a safe default.
What this Sales VP actually cares about
A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. They protect quota, forecast credibility, and rep time, so keep the ask at "a 15-minute look at one metric, not a platform tour."
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Proof that lands: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft.
How should I customize this template before I send it?
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone crisp and commercial.
- If they introduced you, report back after you meet the person.
- Time it for 1-2 days. Within 24 to 48 hours while they still remember your face or handle.
- Don't use consumer-startup slang. It's a credibility leak.
What mistakes should I avoid with this after networking note?
- A generic 'thanks for your time' is forgettable.
- Don't dump a calendar link as the first follow-up unless they asked.
- Don't use consumer-startup slang. It's a credibility leak.
- Telling them how to sell. They've heard it.
How does this after networking scenario compare?
| Dimension | For this template |
|---|---|
| Best send window | 1-2 days |
| Ideal length | 70 to 90 words. Lead with the outcome. |
| Primary ask | a 15-minute look at one metric, not a platform tour |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Crisp and commercial. They can handle a direct ask. |
| Unlike cold email | You have a shared moment. Use it. Writing like a stranger wastes the introduction. |
| Unlike introduction | You already met. Don't re-introduce your whole bio. |
What should I copy and send?
Copy-ready template
Subject
Pharmaceuticals note on follow-up that ignores MLR, off-label risk,
Body
Hi [First Name], Just a note to say thank you for [intro / time / review]. The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. No need to reply. I just wanted this on the record. Given this is after networking, share the resource you promised, or ask if they'd like a short continuation. Hope the rest of your week is quieter than the start. Best, [Your Name] [Your Title] [Your Company]
Questions people ask before they hit send
Human. If you pitch immediately, you retroactively made the chat feel extractive. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. The sales VP is guarding quota, forecast credibility, and rep time, so the ask should stay at "a 15-minute look at one metric, not a platform tour."
Related templates
Want a custom draft instead? Try the email generator.